Molecular requirements of imino sugars for the selective control of N-linked glycosylation and glycosphingolipid biosynthesis

N-Butyl-deoxynojirimycin (NB-DNJ) has been approved for clinical trials as a potential therapy for Gaucher disease, a glycolipid lysosomal storage disorder. As this compound has both glycoprotein processing α-glucosidase and ceramide glucosyltransferase inhibitory activity, we have sought to determi...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Butters, T, van den Broek, L, Fleet, G, Krulle, T, Wormald, M, Dwek, R, Platt, F
פורמט: Journal article
שפה:English
יצא לאור: 2000

פריטים דומים